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Staphylococcus aureus Stimulates Neutrophil
Targeting Chemokine Expression in Keratinocytes
through an Autocrine IL-1a Signaling Loop
Florina Olaru1 and Liselotte E. Jensen1
Staphylococcus aureus is a significant human pathogen that can colonize the skin. Neutrophils are well known
to be involved in clearance of the bacterium. This study focused on exploring the role that human keratinocytes
have as first responders to bacterial challenges. IL-1a and IL-1b increased mRNA production and protein
secretion of the neutrophil chemotactic CXCL1, CXCL2, and IL-8 in keratinocytes. S. aureus and the bacterial cell
wall components lipoteichoic acid (LTA) and peptidoglycan (PGN) induced similar expression profiles in a
Toll-like receptor (TLR)-2-dependent manner. Interestingly, the S. aureus-induced mRNA levels peaked at later
time points than those induced by IL-1. The S. aureus-activated chemokine production was preceded by
significant IL-1a and IL-1b secretion. Expression of IL-1a was significantly higher than that of IL-1b. Inhibition of
IL-1RI using neutralizing antibodies revealed that S. aureus-derived LTA and PGN-induced chemokine
expression requires IL-1RI engagement. Surprisingly, we further found that chemokine secretion is dependent
upon endocrine IL-1a, but not IL-1b, signaling. Our data show that the innate immune response of keratinocytes
is regulated differently than those of other cell types. This may represent a fail-safe system that protects the host
against genetic variation and immune evasion mechanisms developed by pathogens.
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INTRODUCTION
The Gram-positive Staphylococcus aureus bacterium causes
a wide spectrum of human inflammatory diseases, ranging
from benign abscesses, through necrotizing fasciitis to
potentially fatal pneumonia and sepsis. When challenged
by a microorganism, the host must be able to immediately
initiate elimination processes. These are in part activated by
the innate immune system and the Toll-like receptors (TLRs).
TLRs distinguish self from non-self by recognizing pathogen-
associated molecular patterns present on, or in, the micro-
organism but not the host (reviewed in Ishii et al., 2008). Such
motifs include flagellin from the flagellum of motile bacteria
(recognized by TLR5), single- and double-stranded RNA
generated during viral life cycles (sensed by TLR7/8 and
TLR3, respectively), and lipopolysaccharide and lipoteichoic
acid (LTA) from bacteria (bound by TLR4 and TLR2,
respectively). TLRs are expressed not only on innate immune
cells such as macrophages, neutrophils, and dendritic
cells, but also on the adaptive B and T cells. Furthermore,
the receptors can be found on fibroblasts and several types of
epithelial cells (Akira et al., 2006). The engagement of the
TLRs activates complex intracellular signaling pathways that,
through increased production of pro-inflammatory cytokines
and type I IFNs, regulate downstream innate and adaptive
immune responses (Akira et al., 2006).
The S. aureus cell wall contains two potential TLR
activators: LTA and peptidoglycan (PGN). LTA and PGN
from many types of Gram-positive bacteria are typically
recognized by TLR2 (Akira et al., 2006) and several studies
have independently implicated TLR2 in the immune response
against S. aureus. TLR2-deficient mice have a significantly
higher mortality rate than wild-type mice after intravenous
administration of S. aureus (Takeuchi et al., 2000), and
production of tumor necrosis factor-a and IL-6 is lower in
TLR2/ than TLR2þ /þ macrophages treated with heat-killed
S. aureus (HKSA) (Takeuchi et al., 2000). TLR2-deficient mice
are more readily colonized in the nasal cavity than wild-type
mice (Gonzalez-Zorn et al., 2005), and establishment of
subcutaneous infections requires 10-fold more colony-form-
ing units in TLR2þ /þ than in TLR2/ mice (Kristian et al.,
2003). Curiously, neutrophil recruitment and clearance of
subcutaneous bacteria seem to be TLR2 independent in mice
(Miller et al., 2006). These phenotypes are instead dependent
upon IL-1b and IL-1R type I (IL-1RI) signaling (Miller et al.,
2006, 2007).
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IL-1 is a pluri-potent pro-inflammatory cytokine (reviewed
in O’Neill, 2008; Dinarello, 2009). There are two classical
isoforms of IL-1, IL-1a and IL-1b. Although both proteins
initially are expressed as intracellular proteins, they are
released from cells in distinct manners. The IL-1a precursor is
active and is released from dying cells (Dinarello, 2009). In
contrast, the IL-1b precursor requires processing by the
inflammasome and caspase-1 before it is secreted by cells in
a purine receptor P2X7-dependent manner (Franchi et al.,
2009). IL-1a and IL-1b activate expression of many immu-
nologically important genes through the transmembrane
receptor complex, comprising IL-1RI and IL-1R accessory
protein (IL-1RAcP), which is present on most, if not all, cell
types (O’Neill, 2008). The intracellular domain of IL-1RI is
homologous to the intracellular domains of the TLRs (O’Neill,
2008). As a result of this similarity, these distinct receptor
classes activate largely the same intracellular signaling
pathways and transcription factors, including mitogen-acti-
vated protein kinases, activator protein-1, and NF-kB
(O’Neill, 2008). Consequently, such diverse phenotypes as
fever, vasodilation, proliferation, differentiation, adhesion,
and migration (Akira et al., 2006; Dinarello, 2009) are
synchronized to ensure an appropriate immune response.
It has been established that keratinocytes, which are
the main constituents of the epidermal layer of the skin,
express TLRs and produce cytokines when the cells are
exposed to TLR ligands (Lebre et al., 2006 and references
therein). However, the specific involvement of keratinocytes
in initiating and orchestrating immune responses to skin
infections, including S. aureus colonization, is largely
unknown. In this study we report how S. aureus stimulates
production of neutrophil chemoattractive cytokines in human
keratinocytes.
RESULTS
IL-1-stimulated keratinocytes express CXC chemokine mRNAs
and proteins involved in neutrophil chemotaxis
Neutrophils have an essential role in eliminating S. aureus
from the host (Verdrengh and Tarkowski, 1997; Mo¨lne et al.,
2000; DeLeo et al., 2009). It was recently shown that IL-1b,
but not IL-1a, is required for recruitment of neutrophils
to a subcutaneous S. aureus infection (Miller et al., 2007).
However, because of the experimental model, this study did
not address the role of the epidermis and specifically the
keratinocytes. Given the capability of S. aureus to colonize
the skin and because many infections start as abrasions of the
skin, we were interested in evaluating the role of human
keratinocytes in recruiting neutrophils. Using microarray
analyses of chemokine mRNA expression in response to
IL-1, we have previously observed that mRNAs encoding the
neutrophil targeting chemokines, such as CXCL1 and CXCL2,
were upregulated by IL-1 (Sanmiguel et al., 2009). However,
these observations were not further examined.
To validate the CXCL1- and CXCL2-specific array data,
primary human neonatal keratinocytes were treated with
increasing concentrations of IL-1b. After 1.5, 3, 6, and
24 hours, production of mRNA and protein was determined
using real-time reverse transcription-PCR (RT-PCR) and
ELISA, respectively. Expression levels of CXCL1 and CXCL2
mRNA and protein were induced in time- and IL-1b
concentration-dependent manners (Figure 1a and b). Interes-
tingly, after only 1.5 hours, rapid bursts in CXCL1 and CXCL2
mRNA levels were observed in IL-1b-treated keratinocytes
(Figure 1a). Subsequently, levels of the CXCL1 and CXCL2
mRNAs gradually declined. At the 1.5-hour time point, the
CXCL1 and CXCL2 mRNA levels were approximately 30- and
15-fold higher (respectively, Po0.01) in 5 ngml–1 IL-1b-
treated keratinocytes than in medium-only-treated cells
(Figure 1a).
Significantly increased secretion of CXCL1 (Po0.05) and
CXCL2 (Po0.01) could be detected already at 1.5 hours
after IL-1b treatment (Figure 1b). Despite declining mRNA
levels after 1.5 hours, CXCL1 and CXCL2 protein concen-
trations continued to increase throughout the duration of the
experiment (Figure 1b). The differences in mRNA and protein
expression profiles likely reflect differential stabilities of
these molecules. At the 24-hour time point, levels of CXCL1
and CXCL2 in medium from cells treated with 5 ngml–1
IL-1b were approximately 25- and 5-fold, respectively,
which was higher (Po0.01) than in medium from cells not
receiving IL-1b.
It has previously been shown that keratinocyte production
of IL-8 (also known as CXCL8) is induced by S. aureus
(Mempel et al., 2003; Sasaki et al., 2003). Because of the
proximity of the microarray targets for mRNAs encoding IL-8
and the highly expressed Toll-interacting protein, TOLLIP,
our previous expression analyses could not evaluate the
expression of IL-8 (Sanmiguel et al., 2009). Expression of IL-8
mRNA and protein was examined in this study as described
above. In contrast to the expression of the CXCL1 and CXCL2
mRNAs (Figure 1a), IL-8 mRNA levels peaked at 3–6 hours
after stimulation. Approximately 25-fold increases (Po0.01)
in IL-8 mRNA expression were observed in 5 ngml–1 IL-1b-
stimulated keratinocytes compared with untreated cells after
3 and 6 hours (Figure 1c). Levels of IL-8 protein in medium
from cells treated with IL-1b increased in a time- and
concentration-dependent manner throughout the experiment
(Figure 1c). At the 24-hour time point, approximately 12-fold
(Po0.05) higher levels of IL-8 were observed in medium from
cells treated with 5 ngml–1 IL-1b than cells treated with
medium only (Figure 1c).
We have previously shown that IL-1a and IL-1b activate
gene expression in the same manner in keratinocytes
(Sanmiguel et al., 2009). In this study IL-1a and IL-1b also
induced similar CXCL1, CXCL2, and IL-8 mRNA and protein
expression profiles (data not shown). IL-1-induced expression
of CXCL1, CXCL2, and IL-8 was confirmed using several
independent batches of neonatal and adult primary kerati-
nocytes and the stable cell lines, HEK001 and CCD 1106
KERTr cells (KERTr; data not shown).
CXC chemokine expression is regulated by S. aureus and cell
wall components derived from the bacteria
Bacteria are recognized by the host TLRs (Ishii et al., 2008)
that activate an intracellular signaling cascade shared by
IL-1RI (Akira et al., 2006; Boraschi and Tagliabue, 2006;
www.jidonline.org 1867
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O’Neill, 2008). We therefore wondered whether S. aureus
would activate expression of the same CXC chemokines
as IL-1 (Figure 1). It is known that keratinocytes express
antimicrobial peptides, including the anti-staphylococcal
b-defensin 3, which is upregulated by S. aureus (Menzies
and Kenoyer, 2006). To ensure a consistent degree of
keratinocyte activation throughout our experiments, we
chose to use heat-killed bacteria. Primary keratinocytes
were treated with increasing amounts of HKSA, and expres-
sion of CXCL1, CXCL2, and IL-8 was examined as described
above after 1, 3, 6, and 24hours (Figure 2). Time- and
concentration-dependent increases in all three CXC chemokine
mRNA levels were observed after HKSA stimulation
(Figure 2a). Curiously, HKSA-induced mRNA levels peaked
later (Figure 2a) than in response to IL-1 (Figure 1a and c). The
CXCL1 mRNA levels reached maximum induction (2- to 5-fold,
Po0.05) after 3hours with all three amounts of HKSA (Figure
2a). Levels of the CXCL2 and IL-8 mRNAs peaked (9- and 32-
fold induction, respectively, Po0.01) at 6hours with the
highest concentration of HKSA (Figure 2a).
In line with the observed shift in maximum CXC
chemokine mRNA induction by HKSA compared with IL-1,
significantly increased protein expression was also slightly
delayed (Figure 2b compared with Figure 1b and c). The
highest levels of CXCL1, CXCL2, and IL-8 induced by HKSA
after 24 hours (Figure 2b) were comparable to those produced
in response to IL-1 (Figure 1).
LTA and PGN from S. aureus are known to activate
gene expression in macrophages (Takeuchi et al., 1999;
Hashimoto et al., 2006). To evaluate whether the LTA and
PGN derived from S. aureus activate CXC chemokine
expression in keratinocytes in a manner similar to that
induced by the bacterium, cells were in addition to HKSA
(Figure 2) treated with LTA and PGN in increasing amounts
(see Supplementary Figure S1 online). RNA and protein
expression was evaluated after 1, 3, 6, and 24hours. Both
LTA and PGN led to increased CXCL1, CXCL2, and IL-8
(Supplementary Figure S1a–c online) mRNA expression. The
mRNA levels peaked at 3–6 hours (Supplementary Figure
S1a–c online) in agreement with that observed for HKSA
(Figure 2a). Secretion of CXCL1, CXCL2, and IL-8 (Supple-
mentary Figure S1d–f online) protein was also induced by
both LTA and PGN. Although LTA activated gene expression
at lower concentrations than PGN, PGN gave rise to a higher
degree of induction than LTA (Supplementary Figure S1
online). Similar observations were made using several
independent batches of neonatal and adult primary keratino-
cytes, and the stable cell lines HEK001 and KERTr (data not
shown). These observations show that S. aureus can activate
neutrophil targeting CXC chemokine production in keratino-
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Figure 1. IL-1 induces CXC chemokine expression in keratinocytes. Primary neonatal keratinocytes (lot 143) were treated with medium only or increasing
concentrations of IL-1b as indicated. Total RNA and culture medium were collected after 1.5, 3, 6, and 24 hours. (a) CXCL1 and CXCL2 mRNA levels
were determined using real-time reverse transcription PCR (RT-PCR) and the comparative CT method. CXCL1 and CXCL2 mRNA levels were normalized against
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels and graphically represented as mean fold change±SD in comparison to cells treated
with medium only. (b) CXCL1 and CXCL2 protein levels (mean±SD) in the culture medium were determined using ELISA. (c) IL-8 mRNA and protein levels
were determined as described in (a) and (b). *Po0.05 (compared with cells treated with medium only and collected at the same time point). **Po0.01
(compared with cells treated with medium only and collected at the same time point). ND, not determined.
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cytes, possibly through the bacterial cell wall components
LTA and PGN.
S. aureus-, LTA-, and PGN-driven CXC chemokine expression is
TLR2 dependent
It has previously been shown that S. aureus activates
expression of antimicrobial peptides (Menzies and Kenoyer,
2006) and IL-8 (Mempel et al., 2003; Sasaki et al., 2003) in
human keratinocytes through TLR2 (Mempel et al., 2003;
Menzies and Kenoyer, 2006). Curiously, it has also been
reported that neutrophil recruitment to subcutaneous
S. aureus infection sites in mice was independent of TLR2
(Miller et al., 2006).
To test whether TLR2 is involved in driving CXC
chemokine expression in keratinocytes exposed to S. aureus
and its subcomponents, KERTr cells were incubated with
MAb human TLR2-specific antibody (Figure 3a–c). Control
cells received isotype-matched mouse IgG2a. After 2 hours,
medium, HKSA, LTA, or PGN were added to the medium and
cells were incubated for an additional 20 hours, after which
CXC chemokine secretion into the medium was examined. A
borderline significant (P¼ 0.07) 32% decrease in HKSA-
induced CXCL1 expression (Figure 3a) was observed in
samples from MAb hTLR2-incubated cells compared with
control cells. CXCL1 production in response to LTA and
PGN was significantly (Po0.01 and Po0.05, respectively)
reduced by approximately 50% in the presence of MAb
hTLR2 compared with control IgG2a (Figure 3a). HKSA-,
LTA-, and PGN-induced production of CXCL2 (Figure 3a) and
IL-8 (Figure 3a) by cells incubated with MAb hTLR2 was all
also significantly (Po0.01 or Po0.05) reduced by 30–50%
compared with cells incubated with mouse IgG2a.
To verify the involvement of TLR2, the above experiments
were repeated using a polyclonal (PAb) antibody against
hTLR2 (Figure 3d–f). Although increased expression (Po0.01)
of CXCL1 (Figure 3d), CXCL2 (Figure 3e), and IL-8 (Figure 3f)
was observed in response to HKSA, LTA, and PGN in the
presence of normal rat IgG, there was no induction of these
chemokines in the presence of the PAb hTLR2 (Figure 3d–f).
Lower concentrations of the antibodies (MAb and PAb and
appropriate control IgGs) led to less dramatic, but significant,
inhibition of CXC chemokine expression (data not shown).
Similar data were obtained using primary keratinocytes and
HEK001 cells (data not shown). These observations show that
TLR2 regulates CXC chemokine expression in keratinocytes
exposed to S. aureus and cellular components thereof.
IL-1a and IL-1bmRNA and protein levels increase in response to
S. aureus, LTA, and PGN
Our previous microarray analyses of inflammatory gene
expression in keratinocytes identified IL1A and IL1B as
putative target genes regulated by IL-1 (Sanmiguel et al.,
2009). In analogy with the similar induction of CXC
chemokines by IL-1 (Figure 1) and S. aureus (Figure 2 and
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Supplementary Figure S1 online), we speculated that IL-1a
and IL-1b production could be regulated in response to
HKSA, LTA, and/or PGN. To test this hypothesis, expression
of IL-1a and IL-1bmRNA and protein was examined (Figure 4
and Supplementary Figure S2 online) as described above.
Only a modest 1.5-fold increase in IL-1a (Po0.05, Figure 4a)
and no change in IL-1b (Figure 4b) mRNA levels were
observed in cells treated with the highest amount of HKSA
after 1 hour. Surprisingly, dramatic increases in IL-1 secretion
were observed after only 1 hour (Figure 4c and d). An
approximately 6-fold increase in IL-1a (Po0.01, Figure 4c)
and a 15-fold increase in IL-1b (Po0.01, Figure 4d) protein
levels were observed at the 1-hour time point in medium
from cells treated with HKSA. Similar effects were observed
with LTA and PGN (Supplementary Figure S2 online). Given
the lack of a comparable mRNA induction at the same early
time point, these observations strongly suggest that pre-
formed and intracellular stored pools of IL-1a and
IL-1b protein are released from keratinocytes immediately
after exposure to S. aureus.
Significantly increased (1.5- to 3.5-fold, Po0.05) IL-1a
and IL-1bmRNA levels were observed at the 3, 6, and/or 24 h
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Figure 3. CXC chemokine expression is TLR2 dependent. KERTr cells were
pre-treated with TLR2-specific antibodies (gray bars; MAb, monoclonal
mouse (a–c) or PAb, polyclonal rat (d–f)). Control cells were treated with
species- and isotype-matched normal IgG (open bars; mouse IgG2a (a–c) or rat
IgG (d–f)). After 2 hours, medium, HKSA, LTA, or PGN was added to the
medium. Secretion of the CXC chemokines, CXCL1 (a, d), CXCL2 (b, e), and
IL-8 (c, f), was determined after 20 hours by ELISA. Data are shown as
mean±SD. *Po0.05 (compared with same Ig- and medium-treated cells
unless marked otherwise with bar below). **Po0.01 (compared with same
Ig- and medium-treated cells unless marked otherwise with bar below).
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time points after HKSA, LTA, and PGN treatment (Figure 4
and Supplementary Figure S2 online) compared with
medium-only treated cells. These increases in mRNA levels
correlated with 1.5- to 3.5-fold elevated protein levels
(Po0.05, Figure 4 and Supplementary Figure S2 online),
although a transient decrease (compared with the 1-hour time
point) in protein levels was observed at the 3-hour time point
(Figure 4c and d).
Within individual samples, approximately 10-fold more
IL-1a than IL-1b was detected (Figure 4c and d). On the
basis of the RT-PCR CT values, IL-1a mRNA levels were
approximately 8 times higher than IL-1b mRNA levels in
untreated cells (data not shown).
In summary, IL-1a is expressed at higher levels than IL-1b
at both the mRNA and protein level in keratinocytes. After
exposure to S. aureus, or its subcomponents, keratinocytes
rapidly, within 1 hour, release IL-1a and IL-1b into the culture
medium. Subsequently, IL-1a and IL-1b mRNA levels are
increased and de novo synthesized protein is secreted.
TLR ligand-induced CXC chemokine expression is driven by
IL-1RI signaling
The observed CXC chemokine mRNA expression profiles
induced by IL-1 (Figure 1) and S. aureus (Figures 2 and 3)
differed with respect to the time at which the mRNA levels
peaked (before 3 hours for IL-1 and between 3 and 6 hours
for HKSA, LTA, and PGN). Furthermore, increased IL-1
secretion was present within an hour of HKSA, LTA, or PGN
stimulation (Figure 4 and Supplementary Figure S2 online).
These observations led us to hypothesize that IL-1 secretion
and subsequent activation of IL-1RI on the keratinocytes
contribute to the S. aureus-induced chemokine expression.
The involvement of IL-1RI was examined by incubating
primary adult keratinocytes with polyclonal antibodies
specific for human IL-1RI (PAb hIL-1RI) before treatment
with medium only, LTA, or PGN (Figure 5a–c). Control cells
were incubated with normal goat IgG. Efficacy of the
antibody was verified by evaluating inhibition of IL-1a-
and IL-1b-induced production of CXCL1, CXCL2, and IL-8
(Figure 5d).
Pre-incubation of cells with PAb hIL-1RI led to an
approximately 50% reduction (Po0.01) in constitutive
expression of CXCL1 (Figure 5a), CXCL2 (Figure 5b), and
IL-8 (Figure 5c) compared with cells receiving the control
IgG. Cells treated with PAb hIL-1RI completely failed to
respond to PGN with increased production of CXCL1 and
CXCL2 (Figure 5a and b). PGN-induced production of IL-8 in
these cells amounted to only approximately 80 pgml–1 above
levels generated by PAb hIL-1RI and medium-only-treated
cells. In comparison, normal goat IgG and PGN-treated cells
produced approximately 250 pgml–1 more IL-8 than normal
goat IgG and medium-only-treated cells (Figure 5c). Although
PAb hIL-1RI-treated cells did respond to LTA, the levels of
increased production were significantly lower than those
induced in appropriately matched control cells (Figure 5a–c).
For example, normal goat IgG and LTA-treated cells secreted
approximately 5 ngml–1 more CXCL1 than cells treated
with normal goat IgG and medium only (Figure 5a). In
comparison, only approximately 0.9 ngml–1 more CXCL1
was released from PAb hIL-1RI and LTA-treated cells than the
PAb hIL-1RI and medium-only reference cells (Figure 5a).
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Figure 5. Staphylococcus aureus-induced CXC chemokine expression is
dependent upon IL-1RI signaling. (a–c) Primary adult keratinocytes (lot
070504–901) were pre-treated with goat anti-human IL-1RI antibodies
(polyclonal antibody (PAb) hIL-1RI, gray bars) or normal goat IgG (open bars).
After 2 hours, medium, lipoteichoic acid (LTA), or peptidoglycan (PGN)
was added to the medium. Secretion of the CXC chemokines (a) CXCL1,
(b) CXCL2, and (c) IL-8 was determined after 20 hours by ELISA. Data are
shown as mean±SD. *Po0.05 (compared with same Ig- and medium-treated
cells unless marked otherwise with bar below). **Po0.01 (compared with
same Ig- and medium-treated cells unless marked otherwise with bar below).
(d) Cells were pre-treated with PAb hIL-1RI or normal goat IgG for 2 hours.
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Similar observations were made using HEK001 and KERTr
cells (data not shown). The above data show that LTA- and
PGN-mediated CXC chemokine expression requires IL-1RI
engagement.
Constitutive IL-1a expression contributes to constitutive CXC
chemokine expression
To analyze further the mechanism by which IL-1RI mediates
S. aureus-induced CXC chemokine production, we explored
whether the IL-1 secreted by the keratinocytes contributed to
the gene activation. As we observed that inhibition of IL-1RI
signaling reduced constitutive production of the CXC
chemokines (Figure 5a–c), we initially examined the effect
of IL-1a and IL-1b on constitutive CXCL1, CXCL2, and IL-8
expression. Cells were treated with polyclonal antibodies
specific for human IL-1a (PAb hIL-1a) or a monoclonal
antibody recognizing human IL-1b (MAb hIL-1b). Control
cells were incubated with appropriate species- and isotype-
matched normal IgG. Although neutralization of IL-1a
reduced chemokine expression by approximately 50%
(Po0.01), the IL-1b-specific antibody did not affect chemo-
kine expression (Figure 6a).
To confirm the activities and specificities of the antibodies,
cells were pre-treated with PAb hIL-1a, MAb hIL-1b, or
appropriate control IgGs. After 2 hours, cells were further
treated with medium only, IL-1a, or IL-1b, and chemokine
expression was determined after an additional 20-hour
incubation. As expected, PAb hIL-1a blocked IL-1a-induced
chemokine expression (Po0.01) but had no effect upon IL-1b
signaling (Figure 6b). The MAb hIL-1b was confirmed to
efficiently (Po0.01) neutralize 10 ngml–1 IL-1b (Figure 6b), a
concentration significantly exceeding that produced by the
keratinocytes (Figure 4d).
One may speculate that the apparent effect of the PAb
hIL-1a could be because of a nonspecific recognition of an
unrelated protein. To confirm the role of IL-1a in regulating
constitutive production of CXC chemokines, cells were
treated with a monoclonal mouse anti-human IL-1a antibody
(MAb hIL-1a) or normal mouse IgG2a before analyses of
CXCL1, CXCL2, and IL-8 expression (Figure 6c). In agreement
with the observations made with the polyclonal antibody,
chemokine expression by MAb hIL-1a-treated cells were
approximately 30% (Po0.01) of that observed with mouse
IgG2A-treated cells (Figure 6c). Similar data were obtained
using the stable cell lines HEK001 and KERTr (data not
shown). The above observations establish that IL-1a, but not
IL-1b, regulate constitutive CXC chemokine secretion by
keratinocytes.
Variation in constitutive production of the CXC chemo-
kines was observed between different batches of both
neonatal (Figures 1 and 2) and adult primary keratinocytes
(Figures 6 and 7) and the stable cell lines KERTr (Figure 3) and
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HEK001 (data not shown). These lot-to-lot disparities likely
reflect gene polymorphisms in CXCL1, CXCL2, or IL8, and/or
genes regulating expression of these; e.g., IL1A.
Induced CXC chemokine expression is dependent upon IL-1a
but not IL-1b
Studies of subcutaneous S. aureus infections in mice have
indicated that IL-1RI and IL-1b, but not IL-1a, are required for
neutrophil recruitment (Miller et al., 2006, 2007). As
keratinocytes secrete elevated levels of IL-1 in response to
HKSA, LTA, and PGN (Figure 4 and Supplementary Figure S2
online), we wondered whether this could be an autocrine
mechanism regulating increased production of the neutrophil
targeting chemokines such as CXCL1, CXCL2, and IL-8. We
initially performed neutralization experiments as described
above testing the involvement of IL-1b. Surprisingly, we
found that the functionally active (Figure 6b) MAb hIL-1b did
not affect chemokine induction (Figure 7a). In contrast, both
antibodies directed against IL-1a significantly (Po0.05)
inhibited HKSA-, LTA-, and PGN-activated CXCL1, CXCL2,
and IL-8 expression (Figure 7b and c). The levels of increased
production of the three chemokines in the presence of the
IL-1a-neutralizing antibodies were decreased to 25–50%
(Po0.05) of that observed with control cells treated with
normal IgG (Figure 7b and c). Similar observations were
made using HEK001 cells (data not shown). Our data show
that both constitutive- and S. aureus-induced neutrophil
targeting CXC chemokine expression in keratinocytes is
regulated by an endocrine signaling pathway involving
IL-1a, but not IL-1b.
DISCUSSION
It is well established that neutrophils have an important role
in eliminating S. aureus from the host in general (Verdrengh
and Tarkowski, 1997; DeLeo et al., 2009 and references
therein) and from the skin specifically (Mo¨lne et al., 2000).
S. aureus infections may initially involve colonization of the
skin and/or the nasal cavity and compromised epithelial
barrier function (van Belkum, 2006). When the skin is injured
the keratinocytes are likely to be the first to encounter an
invading potential pathogen. To ensure that the challenge is
cleared before the microorganism can multiply and spread,
the keratinocytes must send danger signals into the surround-
ing tissue to summon, for example, neutrophils. The data
reported in this study show that S. aureus-exposed keratino-
cytes produce chemokines (CXCL1, CXCL2, and IL-8; Figures
2 and 3) that are chemotactic to neutrophils. Interestingly, the
TLR2-dependent (Figure 3) chemokine induction requires an
endocrine IL-1a, but not IL-1b, signaling loop (Figures 4–7).
Initially, it may be puzzling that although the keratinocytes
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produce both IL-1a and IL-1b, only IL-1a has a functional
effect. However, it should be noticed that the keratinocytes
secrete significantly (Po0.01) more IL-1a (Figure 4c) than
IL-1b (Figure 4d) and the levels of IL-1b synthesis may be
insufficient to significantly affect gene expression.
It has previously been reported that IL-1 signaling, through
IL-1RI, is required for neutrophil recruitment to a subcuta-
neous S. aureus challenge in mice (Miller et al., 2006). It was
furthermore showed that IL-1b, but not IL-1a, was the
functional isoform (Miller et al., 2007). We chose to examine
specifically the role that keratinocytes have as first responders
to microbial challenges. Our data show that chemokine
expression in keratinocytes is regulated differently than in the
(un-indentified) cell types involved in the in vivo model; i.e.,
it is TLR2 and IL-1a, but not IL-1b, dependent. The different
outcomes (IL-1a vs. IL-1b dependence) of using various
models may reflect repetition, yet variation, in the immune
system that is required to ensure proper protection against
immune evasion mechanisms developed by pathogenic
microorganisms and genetic variation in the host. S. aureus
has acquired several virulence factors aimed at inhibiting
neutrophil chemotaxis (reviewed in Rooijakkers et al., 2005;
Kraus and Peschel, 2008). A multi-layered IL-1 system
involving keratinocytes and IL-1a (as reported in this study)
as initial responders in the skin and IL-1b as the activator used
by other cell types in the epidermis and underlying tissues
(Miller et al., 2007) may provide a fail-safe scheme in which
one mechanism can substitute for the other should this fall
short of its task. It should be noted that we did observe
expression of IL-1b in keratinocytes after activation by
S. aureus (Figure 4). The levels of IL-1b expressed by the
keratinocytes seemed to be too low to have a functional effect
in our model (Figures 6 and 7). However, there may be
situations in which IL-1a is inactive, e.g., mutations in the
host, or becomes depleted. In these situations IL-1b may
substitute for IL-1a in the epidermis.
The review literature on TLR and IL-1RI signaling often
mentions that these receptors activate the same (Akira et al.,
2006; Boraschi and Tagliabue, 2006) or similar signaling
pathways (O’Neill, 2008). Not surprisingly, we observed that
the TLR2 ligands (HKSA, LTA, and PGN;, Figure 2 and
Supplementary Figure S1 online) increased expression of the
same CXC chemokine genes activated by IL-1 (Figure 1).
Given that the used TLR2 ligands also led to secretion of IL-1
(Figure 4), we anticipated that IL-1 would be partially
responsible for the TLR2 ligand-induced CXC chemokine
expression. Surprisingly, we found that TLR2 ligand-induced
CXC chemokine expression could be completely blocked by
antibodies directed against IL-1RI (Figure 5). This implies that
TLR2 signaling does not directly regulate CXC chemokine
expression, but requires IL-1 secretion and signaling as an
intermediate step (TLR2-IL-1-IL-1RI-CXC chemokine).
This may further indicate that the IL-1RI and TLRs do not
strictly activate the same signaling pathways. The intracel-
lular regions of IL-1RI and the TLRs contain a conserved
protein–protein interaction domain involved in binding the
adapter protein MyD88 (Akira et al., 2006; O’Neill, 2008;
Dinarello, 2009). One known difference between IL-1RI and
TLR2 signaling is the specific requirement for the adapter
protein toll-interleukin 1 receptor domain containing adaptor
protein (TIRAP) in TLR2, but not IL-1RI, signaling. TIRAP
facilitates the recruitment of MyD88 to the TLR2 receptor
complex (Akira et al., 2006; O’Neill, 2008). It has been
shown that knockout of TIRAP impairs TLR2 (and TLR4)-
mediated cytokine expression in macrophages and dendritic
cells. Induction of the same cytokines by other TLR ligands or
IL-1 was not affected (Horng et al., 2002; Yamamoto et al.,
2002). It is possible that TIRAP, through an unknown
mechanism, could facilitate a differential gene expression
profile compared with those induced by MyD88-restricted
pathways. An alternative, or perhaps complementary, hypoth-
esis is that scaffolds have an essential role in regulating which
genes are activated in response to certain stimuli. Such
scaffolds could involve the Pellino proteins as previously
described (Jensen and Whitehead, 2003a, b), or some of the
many proteins involved in regulating mitogen-activated protein
kinase signaling (reviewed in Morrison and Davis, 2003).
TLR2 requires a coreceptor, TLR1 or TLR6, for ligand
binding; however, the specific functional involvement of
these cofactors remains controversial (Fournier and Philpott,
2005). We observed that hTLR2 MAb had only a borderline
significant effect upon CXCL1 expression (Figure 3a),
whereas the hTLR2 PAb abolished CXCL1 expression
(Figure 3d). It is likely that the used mono- and polyclonal
antibodies have differential effects upon heterodimer forma-
tion between TLR2 and the cofactors TLR1 and TLR6.
Furthermore, the cofactors may have diverging roles in
downstream signaling. Further studies are required to
determine whether TLR1 and TLR6 have specific functions
in terms of the range of chemokines expressed in response to
distinct S. aureus-derived ligands.
Interestingly, we observed variations in the constitutive
levels of the three neutrophil chemotactic chemokines,
CXCL1, CXCL2, and IL-8 (compare Figures 1, 2, 5 and 6;
medium-only-treated samples), between lot numbers of
primary cells. This could be due to genetic variations in the
CXC chemokine genes and/or genes regulating their expres-
sion. Differences in constitutive expression of chemokines,
and other innate immune factors, may determine whether an
individual becomes an intermittent or chronic carrier of
S. aureus. Furthermore, as the starting degree of expression
may influence the levels during inflammation, polymor-
phisms in the CXC chemokine genes, or their regulators, may
also affect the outcome of an infection. Comprehensive
studies involving genome-wide analyses of gene expression
and polymorphisms may reveal patterns associated with S.
aureus carrier status and infections. Analyses of such profiles
in the context of further characterization of the multifaceted
immune system activated in response to S. aureus may reveal
mechanisms by which effective prophylactic and/or treat-
ment strategies can be achieved.
MATERIALS AND METHODS
Cell cultures
Neonatal foreskin (pooled) and adult torso human primary kerati-
nocytes were obtained from Invitrogen (Carlsbad, CA). The human
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keratinocyte cell lines HEK001 (CRL-2404) and CCD 1106 KERTr
(KERTr, CRL-2309) were obtained from ATCC (Manassas, VA). Cells
were maintained and treated in defined keratinocyte serum-free
medium supplemented with 50 mgml–1 gentamicin (Invitrogen).
Activation of cell cultures. Cell cultures were grown to
approximately 80–90% confluence and treated with medium only,
IL-1a (National Cancer Institute, Frederick, MD), IL-1b (PeproTech,
Rocky Hill, NJ), HKSA (Invivogen, San Diego, CA), purified LTA
(Invivogen), and PGN (Invivogen) as indicated in figures. The HKSA,
LTA, and PGN were all derived from S. aureus strain ATCC 6538.
Bacteria were purchased heat-killed from Invivogen. In brief,
bacteria were killed by one or more 15-minute cycles of autoclaving
at 121 1C. Cells were pelleted by centrifugation and resuspended in
water. Lack of viability was confirmed by solid- and liquid-state
cultures for 5 days.
Neutralization experiments. Mouse monoclonal IgG2a (MAb
hTLR2) and polyclonal rat (PAb hTLR2) antibodies directed against
human TLR2 were obtained from Invivogen. Polyclonal rabbit
antibody against human IL-1a (500-P21A) was from PeproTech.
Monoclonal mouse antibodies specific for human IL-1a (IgG2a,
MAB200) and IL-1b (IgG1, MAB601), and polyclonal goat antibodies
against human IL-1RI (AF269) were obtained from R&D Systems
(Minneapolis, MN). Purified normal goat IgG, mouse IgG1, mouse
IgG2A, rabbit IgG, and rat IgG were obtained from R&D Systems. For
inhibition of TLR2 signaling, cells were pre-incubated with 50mgml–1
MAb hTLR2, 100mgml–1 PAb hTLR2, normal mouse IgG2a, or normal
rat IgG for 2 hours. In IL-1 signaling neutralization experiments, cells
were pre-incubated with 10mgml–1 antigen-specific antibodies or
species- and isotype-matched control antibodies for 2 hours. After
pre-incubating medium only, HKSA (109 cellsml–1 final concentra-
tion), LTA (10mgml–1 final concentration), or PGN (250mgml–1 final
concentration) was added to the antibody containing medium, and
incubation was continued for an additional 20hours before
chemokine expression was determined by ELISA. All experiments
were performed at least three times with similar outcomes.
RNA isolation and real-time RT-PCR
Total RNA was extracted using the RNeasy purification system
according to the manufacturer’s instructions (Qiagen, Valencia, CA).
Reverse transcription (RT) and real-time PCR was performed as
described elsewhere (Sanmiguel et al., 2009). In brief, 1mg total RNA
was reverse transcribed using Avian Myeloblastosis Virus reverse
transcriptase (Promega, Madison, WI) and oligo(dN)6 primer (GE
Healthcare, Piscataway, NJ). Real-time RT-PCR was performed using
RT2 Real-Time SYBR Green PCR Master Mix (SABiosciences,
Frederick, MD) on an Opticon2 instrument (Bio-Rad, Hercules,
CA). Primer pairs (Supplementary Table S1 online) specific for
individual mRNA/complementary DNAs were designed such that
PCR products (80–100 bp) span exon–-exon junctions, thereby
preventing amplification of genomic DNA. Assays were validated
using serial dilutions and confirmation of equal amplification
efficiencies of the complementary DNA of interest and the
glyceraldehyde-3-phosphate dehydrogenase complementary DNA.
Fold differences in expression were calculated using the comparative
CT method by standardizing against glyceraldehyde-3-phosphate
dehydrogenase expression and comparing expression in cytokine-
or TLR ligand-treated cells to expression in cells treated with
medium only.
ELISA
CXCL1 and IL-1b concentrations in culture medium from stimulated
cells were determined using the appropriate DuoSet ELISA develop-
ment kits (R&D Systems). CXCL2, IL-1a, and IL-8 levels were
determined using ELISA development assays from PeproTech.
Statistical analyses
Data are shown as mean values and SD from one representative
experiment of at least three independent experiments. Data were
analyzed using the Student’s t-test when appropriate.
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